2,891 reports of this reaction
1.3% of all OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN reports
#18 most reported adverse reaction
WITHDRAWAL SYNDROME is the #18 most commonly reported adverse reaction for OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, manufactured by Endo USA, Inc.. There are 2,891 FDA adverse event reports linking OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN to WITHDRAWAL SYNDROME. This represents approximately 1.3% of all 222,803 adverse event reports for this drug.
OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN has an overall safety score of 92 out of 100. Patients taking OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN who experience withdrawal syndrome should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
WITHDRAWAL SYNDROME is a less commonly reported adverse event for OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, but still significant enough to appear in the safety profile.
In addition to withdrawal syndrome, the following adverse reactions have been reported for OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN:
The following drugs have also been linked to withdrawal syndrome in FDA adverse event reports:
WITHDRAWAL SYNDROME has been reported as an adverse event in 2,891 FDA reports for OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN. This does not prove causation, but indicates an association observed in post-market surveillance data.
WITHDRAWAL SYNDROME accounts for approximately 1.3% of all adverse event reports for OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, making it a notable side effect.
If you experience withdrawal syndrome while taking OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.